MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia
ABSTRACT Background/purpose Community‐acquired pneumonia (CAP) is a disease with high morbidity and mortality. Adherence to clinical practice guidelines (CPGs) in treatment of CAP is associated with favourable outcome. We aimed to develop and validate a medication assessment tool (MAT) to explore ad...
Published in: | Pharmacoepidemiology and Drug Safety |
---|---|
Main Authors: | , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Wiley
2014
|
Subjects: | |
Online Access: | http://dx.doi.org/10.1002/pds.3640 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpds.3640 https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.3640 |
id |
crwiley:10.1002/pds.3640 |
---|---|
record_format |
openpolar |
spelling |
crwiley:10.1002/pds.3640 2024-06-02T08:11:50+00:00 MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia Høgli, June Utnes Småbrekke, Lars Garcia, Beate Hennie 2014 http://dx.doi.org/10.1002/pds.3640 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpds.3640 https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.3640 en eng Wiley http://onlinelibrary.wiley.com/termsAndConditions#vor Pharmacoepidemiology and Drug Safety volume 23, issue 9, page 933-941 ISSN 1053-8569 1099-1557 journal-article 2014 crwiley https://doi.org/10.1002/pds.3640 2024-05-03T11:19:46Z ABSTRACT Background/purpose Community‐acquired pneumonia (CAP) is a disease with high morbidity and mortality. Adherence to clinical practice guidelines (CPGs) in treatment of CAP is associated with favourable outcome. We aimed to develop and validate a medication assessment tool (MAT) to explore adherence to CPG recommendations in patients with CAP admitted to a Norwegian hospital. The tool is named MAT‐CAP. Method Sixteen quality indicators (QIs) based on local and international CPGs were developed. Content validity was explored in an expert panel using a two‐round modified Delphi technique. QIs demonstrating content valdity were reformulated into review criteria forming the MAT‐CAP. Feasibility and adherence to MAT‐CAP were explored in a retrospective study using data from electronic patient records of CAP patients admitted to the University Hospital of North Norway Tromso during 2008. Reliability was explored using Cohen's kappa (ĸ) statistics for inter‐ and intra‐observer agreements. Results Content validity was demonstrated for 15 QIs covering areas as initial empirical treatment, microbiological diagnostics, pathogen specific treatment, dose adjustment according to renal function, switch from intravenous to oral treatment and treatment duration. Overall reliability was excellent with ĸ‐values of 0.88 and 0.95 for inter‐observer and intra‐observer agreements, respectively. Overall applicability was 37.2%, and mean application times were 3.1 and 3.8 min for the two observers. Overall adherence to 812 criteria applied was 59% (range 0–100). Conclusions We have demonstrated content validity, feasibility and reliability of a 15‐criterion MAT‐CAP. Adherence results from applying MAT‐CAP criteria pinpointed areas with good clinical performance and areas with improvement potentials. Copyright © 2014 John Wiley & Sons, Ltd. Article in Journal/Newspaper North Norway Tromso Tromso Wiley Online Library Norway Tromso ENVELOPE(16.546,16.546,68.801,68.801) Pharmacoepidemiology and Drug Safety 23 9 933 941 |
institution |
Open Polar |
collection |
Wiley Online Library |
op_collection_id |
crwiley |
language |
English |
description |
ABSTRACT Background/purpose Community‐acquired pneumonia (CAP) is a disease with high morbidity and mortality. Adherence to clinical practice guidelines (CPGs) in treatment of CAP is associated with favourable outcome. We aimed to develop and validate a medication assessment tool (MAT) to explore adherence to CPG recommendations in patients with CAP admitted to a Norwegian hospital. The tool is named MAT‐CAP. Method Sixteen quality indicators (QIs) based on local and international CPGs were developed. Content validity was explored in an expert panel using a two‐round modified Delphi technique. QIs demonstrating content valdity were reformulated into review criteria forming the MAT‐CAP. Feasibility and adherence to MAT‐CAP were explored in a retrospective study using data from electronic patient records of CAP patients admitted to the University Hospital of North Norway Tromso during 2008. Reliability was explored using Cohen's kappa (ĸ) statistics for inter‐ and intra‐observer agreements. Results Content validity was demonstrated for 15 QIs covering areas as initial empirical treatment, microbiological diagnostics, pathogen specific treatment, dose adjustment according to renal function, switch from intravenous to oral treatment and treatment duration. Overall reliability was excellent with ĸ‐values of 0.88 and 0.95 for inter‐observer and intra‐observer agreements, respectively. Overall applicability was 37.2%, and mean application times were 3.1 and 3.8 min for the two observers. Overall adherence to 812 criteria applied was 59% (range 0–100). Conclusions We have demonstrated content validity, feasibility and reliability of a 15‐criterion MAT‐CAP. Adherence results from applying MAT‐CAP criteria pinpointed areas with good clinical performance and areas with improvement potentials. Copyright © 2014 John Wiley & Sons, Ltd. |
format |
Article in Journal/Newspaper |
author |
Høgli, June Utnes Småbrekke, Lars Garcia, Beate Hennie |
spellingShingle |
Høgli, June Utnes Småbrekke, Lars Garcia, Beate Hennie MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia |
author_facet |
Høgli, June Utnes Småbrekke, Lars Garcia, Beate Hennie |
author_sort |
Høgli, June Utnes |
title |
MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia |
title_short |
MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia |
title_full |
MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia |
title_fullStr |
MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia |
title_full_unstemmed |
MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia |
title_sort |
mat‐cap: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia |
publisher |
Wiley |
publishDate |
2014 |
url |
http://dx.doi.org/10.1002/pds.3640 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpds.3640 https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.3640 |
long_lat |
ENVELOPE(16.546,16.546,68.801,68.801) |
geographic |
Norway Tromso |
geographic_facet |
Norway Tromso |
genre |
North Norway Tromso Tromso |
genre_facet |
North Norway Tromso Tromso |
op_source |
Pharmacoepidemiology and Drug Safety volume 23, issue 9, page 933-941 ISSN 1053-8569 1099-1557 |
op_rights |
http://onlinelibrary.wiley.com/termsAndConditions#vor |
op_doi |
https://doi.org/10.1002/pds.3640 |
container_title |
Pharmacoepidemiology and Drug Safety |
container_volume |
23 |
container_issue |
9 |
container_start_page |
933 |
op_container_end_page |
941 |
_version_ |
1800758097840439296 |